Diagnostic bronchoscopy is effective as a tool for patients with COPD

Performing Procedures

Is Diagnostic Bronchoscopy Safe in Patients with COPD?

“Given the high and rising global burden of COPD, a revolution in the diagnosis and management of COPD and exacerbations of COPD in low and middle income countries must be an urgent priority.”

Diagnostic bronchoscopy is an effective tool for patients with chronic obstructive pulmonary disease (COPD) and its related diseases, according to a new systematic review and meta-analysis.

“The major complication rate of diagnostic bronchoscopy in patients with COPD was acceptable and low,” write Dr. Congcong Li and others in a study out of China published in Expert Review of Respiratory Medicine.

Because COPD is a major risk factor for lung cancer and infection and often coexists with other diseases, there was concern that the weaker status of those patients could lead to more serious complications when bronchoscopy was performed.

COPD refers to a group of diseases that cause airflow blockage and breathing problems for an estimated 16 million Americans who suffer from the affliction, according to the Centers for Disease Control and Prevention. (CDC).

The research examined 18 trials and found the major complication rate of bronchoscopy to be about 4.3 percent. Patients experiencing a COPD flareup showed a higher complication rate of 7.8 percent. The use of sedative medicine also was related to more complications, the authors write.

These findings “reminded us to be more cautious when conducting bronchoscopies in this patient population,” the researchers add.

COPD was the fourth-leading cause of death in the U.S. in 2018, based on the most current statistics available.

As baby boomers age, COPD has become a growing problem, and respiratory therapists are increasingly taking on the role of COPD navigators who help patients get proper treatment, along with education and follow up care to try to prevent additional flareups of the disease.

Worldwide, COPD is expected to become the leading cause of death by 2033, according to doctors S.A. Quaderi and J.R. Hurst in the “Unmet Global Burden of COPD” in Global Health, Epidemiology and Genomics.

“Given the high and rising global burden of COPD, a revolution in the diagnosis and management of COPD and exacerbations of COPD in low and middle income countries (LMICs) must be an urgent priority,” those authors write.

More Pulmonology Articles
Are You Following The Right Pulmonology Influencers?
Best Practices
For a broader look at social media in the medical world, the Healthcare Hashtag Project describes itself as a platform that connects doctors, caregivers, patient advocates and other providers to relevant conversations and communities.
Healthcare Shortage Means High Caseloads for Physicians
Public Health
A ranking of specialties by caseload answers the question of which physicians are responsible for the highest number of patients. Wonder where your specialty comes in?
More From Single-Use Endoscopy
Consensus Opinions on Single-Use Bronchoscope Use in China

Endoscopy Tech

Surveys yield a dozen recommendations based on the key attributes of single-use bronchoscopes.

Single-Use Therapeutic Gastroscope Obtains FDA Clearance

Emerging Technologies

The novel device features a 4.2mm working channel and expands Ambu's portfolio of single-use endoscopes for upper gastrointestinal (GI) procedures.

3 Things Worth Checking Out at AUA 2024

Public Health

Panel discussions and sessions will be in the spotlight during AUA 2024 — running May 3rd to May 6th — addressing a broad spectrum of subjects.